Literature DB >> 2240164

Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.

T R Ulich1, K Z Guo, B Irwin, D G Remick, G N Davatelis.   

Abstract

Tumor necrosis factor alpha (TNF alpha) mRNA is present in a preformed intracellular pool in the spleen, liver, and small bowel of naive rats. Endotoxin (Salmonella typhus lipopolysaccharide) injected intravenously induces little or no increase in whole-organ TNF mRNA levels at 15', 30', 1 degree, 2 degrees, or 4 degrees, whereas serum TNF levels are markedly elevated at 1 and 2 hours. Dexamethasone pretreatment of rats suppresses LPS-induced serum TNF concentrations, but does not suppress TNF mRNA levels in the spleen or bowel. Tachyphylaxis experiments demonstrate that a second injection of endotoxin 2 hours after an initial injection fails to induce a second peak of serum TNF, although TNF mRNA levels in the spleen and bowel remain at the levels found in naive rats. Corynebacterium parvum upregulates endotoxin-induced serum TNF release and intravenous injection of IL-1 induces the release of serum TNF but neither alters whole-organ TNF mRNA levels. Interleukin-1 alpha (IL-1 alpha) mRNA was not constitutively detected in whole-organ RNA preparations of the spleen, liver, and small bowel of naive rats. Endotoxin induces IL-1 alpha mRNA most easily appreciated in the spleen beginning at 1 hour, peaking at 2 to 4 hours, and disappearing by 6 hours. Interleukin-1 beta (IL-1 beta) mRNA was not constitutively detected in the organs examined or was present in small amounts. Endotoxin induces IL-1 beta mRNA beginning at 0.5 hours, peaking at 1 hour, and disappearing by 6 hours. Dexamethasone pretreatment prevents the LPS-induced appearance of IL-1 alpha mRNA and suppresses but does not completely inhibit the appearance of IL-1 beta mRNA. C. parvum upregulates endotoxin-induced IL-1 mRNA expression. Intravenous injection of TNF or IL-1 both induce IL-1 mRNA expression. In conclusion, TNF mRNA is constitutively expressed and TNF mRNA levels as analyzed in whole-organ RNA preparations do not change in concert with serum TNF protein levels during conditions of endotoxemia, dexamethasone treatment, tachyphylaxis, priming with C. parvum, or after injection of IL-1. In contrast, IL-1 mRNA expression during endotoxemia, dexamethasone treatment, priming with C. parvum, or after injection of TNF or IL-1 shows clear increases and decreases in whole-organ RNA preparations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240164      PMCID: PMC1877675     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.

Authors:  T R Ulich; J del Castillo; R X Ni; N Bikhazi
Journal:  J Leukoc Biol       Date:  1989-06       Impact factor: 4.962

2.  Translational blockade imposed by cytokine-derived UA-rich sequences.

Authors:  V Kruys; O Marinx; G Shaw; J Deschamps; G Huez
Journal:  Science       Date:  1989-08-25       Impact factor: 47.728

3.  Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels.

Authors:  D G Remick; D T Nguyen; M K Eskandari; R M Strieter; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

Review 5.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

6.  Suppression of human leukocyte tumor necrosis factor secretion by the serine protease inhibitor p-toluenesulfonyl-L-arginine methyl ester (TAME).

Authors:  P Scuderi
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

7.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.

Authors:  P R Bachwich; S W Chensue; J W Larrick; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

8.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

10.  Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1.

Authors:  P P Nawroth; I Bank; D Handley; J Cassimeris; L Chess; D Stern
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  31 in total

1.  Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation.

Authors:  T R Ulich; S C Howard; D G Remick; E S Yi; T Collins; K Guo; S Yin; J L Keene; J J Schmuke; C N Steininger
Journal:  Inflammation       Date:  1994-08       Impact factor: 4.092

2.  Delayed addition of glucocorticoids selectively suppresses cytokine production in stimulated human whole blood.

Authors:  Devin L Horton; Daniel G Remick
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

3.  Rabbit cardiac and skeletal myocytes differ in constitutive and inducible expression of the glucose-regulated protein GRP94.

Authors:  M Vitadello; P Colpo; L Gorza
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

4.  The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate.

Authors:  T R Ulich; L R Watson; S M Yin; K Z Guo; P Wang; H Thang; J del Castillo
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Dexamethasone prevents autoimmune nephritis and reduces renal expression of Ia but not costimulatory signals.

Authors:  A M Jevnikar; G G Singer; D C Brennan; H W Xu; V R Kelley
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

6.  The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.

Authors:  B P Giroir; J H Johnson; T Brown; G L Allen; B Beutler
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Interleukin-1beta mediates endotoxin- and tumor necrosis factor alpha-induced RGS16 protein expression in cultured cardiac myocytes.

Authors:  Monica Patten; Sabine Stübe; Bryan Thoma; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

8.  Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.

Authors:  T R Ulich; K Guo; S Yin; J del Castillo; E S Yi; R C Thompson; S P Eisenberg
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration.

Authors:  C D Breder; C Hazuka; T Ghayur; C Klug; M Huginin; K Yasuda; M Teng; C B Saper
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 10.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.